Evidence map›Paper›PMID 30653506›Full record

ArticlePLoS genetics2019

Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry.

Calvin Chi, Xiaorong Shao, Brooke Rhead, Edlin Gonzales, Jessica B Smith, Anny H Xiang, Jennifer Graves, Amy Waldman, Timothy Lotze, Teri Schreiner and 23 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Admixture mapping identifies complex trait associations with local ancestry in themedRxiv : the preprint server for health sciences · 2025
    Article
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Racial and Ethnic Disease Phenotype Differences Are Driven by Genetics: Commentary.Multiple sclerosis (Houndmills, Basingstoke, England) · 2024
    Article
  10. Prevalence of neuromyelitis optica spectrum disorder in the United States.Multiple sclerosis (Houndmills, Basingstoke, England) · 2024
    Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 19 institutions in 1 country.

Calvin ChiGenetic Epidemiology and Genomics Laboratory, University of California, Berkeley, Berkeley, California, United States of America.ORCID 0000-0002-4757-0559
Xiaorong ShaoGenetic Epidemiology and Genomics Laboratory, University of California, Berkeley, Berkeley, California, United States of America.
Brooke RheadGenetic Epidemiology and Genomics Laboratory, University of California, Berkeley, Berkeley, California, United States of America.ORCID 0000-0002-1839-4883
Edlin GonzalesDepartment of Research & Evaluation, Kaiser Permanente Southern California, Los Angeles, California, United States of America.
Jessica B SmithDepartment of Research & Evaluation, Kaiser Permanente Southern California, Los Angeles, California, United States of America.
Anny H XiangDepartment of Research & Evaluation, Kaiser Permanente Southern California, Los Angeles, California, United States of America.
Jennifer GravesDepartment of Neurology, University of California, San Francisco, San Francisco, California, United States of America.
Amy WaldmanLeukodystrophy Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.
Timothy LotzeNeurology and Developmental Neuroscience Department, Texas Children's Hospital, Houston, Texas, United States of America.
Teri SchreinerUniversity of Colorado School of Medicine, Aurora, Colorado, United States of America.
Bianca Weinstock-GuttmanDepartment of Neurology, State University of New York, Buffalo, Buffalo, New York, United States of America.ORCID 0000-0001-6732-151X
Gregory AaenLoma Linda University, Loma Linda, California, United States of America.
Jan-Mendelt TillemaDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, United States of America.
Jayne NessChildren's of Alabama, Birmingham, Alabama, United States of America.
Meghan CandeeDepartment of Pediatrics, University of Utah, Salt Lake City, Utah, United States of America.
Lauren KruppDepartment of Neurology, NYU Langone Health, New York, New York, United States of America.
Mark GormanBoston Children's Hospital, Boston, Massachusetts, United States of America.
Leslie BensonBoston Children's Hospital, Boston, Massachusetts, United States of America.
Tanuja ChitnisMassGeneral Hospital for Children, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Soe MarDepartment of Neurology, Washington University School of Medicine in St. Louis, St. Louis, Missouri, United States of America.
Anita BelmanDepartment of Neurology, NYU Langone Health, New York, New York, United States of America.
Theron Charles CasperDepartment of Pediatrics, University of Utah, Salt Lake City, Utah, United States of America.
John RoseDepartment of Neurology, University of Utah, Salt Lake City, Utah, United States of America.
Manikum MoodleyCenter for Pediatric Neurosciences, Cleveland Clinic, Cleveland, Ohio, United States of America.
Mary RenselMellen Center, Cleveland Clinic, Cleveland, Ohio, United States of America.
Moses RodriguezDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, United States of America.
Benjamin GreenbergNeurology & Neurotherapeutics, University of Texas Southwestern, Dallas, Texas, United States of America.ORCID 0000-0002-2091-8201
Llana KahnChildren's National Medical Center, Northwest Washington, D.C., United States of America.ORCID 0000-0002-0510-0276
Jennifer RubinAnn & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States of America.
Catherine SchaeferKaiser Permanente Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America.
Emmanuelle WaubantDepartment of Neurology, University of California, San Francisco, San Francisco, California, United States of America.
Annette Langer-GouldKaiser Permanente, Southern California Permanente Medical Group, Pasadena, California, United States of America.
Lisa F BarcellosGenetic Epidemiology and Genomics Laboratory, University of California, Berkeley, Berkeley, California, United States of America.ORCID 0000-0002-0303-3479
Kaiser Permanente · USUniversity of California, Berkeley · USUniversity of Utah · USBoston Children's Hospital · USCleveland Clinic · USMayo Clinic · USNYU Langone Health · USUniversity of California, San Francisco · USChildren's Hospital of Philadelphia · USChildren's National · USChildren's of Alabama · USLoma Linda University · USLurie Children's Hospital · USMassachusetts General Hospital · USTexas Children's Hospital · USThe University of Texas Southwestern Medical Center · USUniversity at Buffalo, State University of New York · USUniversity of Colorado Denver · USWashington University in St. Louis · US

Funding

A Resource for Genetic Epidemiology Research in Adult Health and AgingRC2AG036607 · NIA · KAISER FOUNDATION RESEARCH INSTITUTE · PI RISCH, NEIL J., SCHAEFER, CATHERINE ANN · 2009 to 2010
$24.8M
The Identification of Risk Factors for the Complex MS PhenotypeR01AI076544 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI BARCELLOS, LISA F · 2008 to 2012
$3.6M
Novel Strategies to Identify GxE Contributions to MS PathogenesisR01ES017080 · NIEHS · UNIVERSITY OF CALIFORNIA BERKELEY · PI BARCELLOS, LISA F · 2011 to 2015
$3.0M
Environmental and genetic risk factors for pediatric MSR01NS071463 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WAUBANT, EMMANUELLE LAURENCE · 2010 to 2015
$2.8M
Genetic and non-genetic risk factors in MSR01NS049510 · NINDS · UNIVERSITY OF CALIFORNIA BERKELEY · PI BARCELLOS, LISA F · 2005 to 2009
$2.7M
Establishing the Causal Role of Low Vitamin D in Multiple SclerosisF31NS096885 · NINDS · UNIVERSITY OF CALIFORNIA BERKELEY · PI RHEAD, BROOKE · 2016 to 2019
$125k
NIAID NIH HHS R01 AI076544NIA NIH HHS RC2 AG036607NIEHS NIH HHS R01 ES017080NINDS NIH HHS F31 NS096885NINDS NIH HHS R01 NS049510NINDS NIH HHS R01 NS071463
6 · The paper itself

Abstract

Multiple sclerosis (MS) is an autoimmune disease with high prevalence among populations of northern European ancestry. Past studies have shown that exposure to ultraviolet radiation could explain the difference in MS prevalence across the globe. In this study, we investigate whether the difference in MS prevalence could be explained by European genetic risk factors. We characterized the ancestry of MS-associated alleles using RFMix, a conditional random field parameterized by random forests, to estimate their local ancestry in the largest assembled admixed population to date, with 3,692 African Americans, 4,915 Asian Americans, and 3,777 Hispanics. The majority of MS-associated human leukocyte antigen (HLA) alleles, including the prominent HLA-DRB1*15:01 risk allele, exhibited cosmopolitan ancestry. Ancestry-specific MS-associated HLA alleles were also identified. Analysis of the HLA-DRB1*15:01 risk allele in African Americans revealed that alleles on the European haplotype conferred three times the disease risk compared to those on the African haplotype. Furthermore, we found evidence that the European and African HLA-DRB1*15:01 alleles exhibit single nucleotide polymorphism (SNP) differences in regions encoding the HLA-DRB1 antigen-binding heterodimer. Additional evidence for increased risk of MS conferred by the European haplotype were found for HLA-B*07:02 and HLA-A*03:01 in African Americans. Most of the 200 non-HLA MS SNPs previously established in European populations were not significantly associated with MS in admixed populations, nor were they ancestrally more European in cases compared to controls. Lastly, a genome-wide search of association between European ancestry and MS revealed a region of interest close to the ZNF596 gene on chromosome 8 in Hispanics; cases had a significantly higher proportion of European ancestry compared to controls. In conclusion, our study established that the genetic ancestry of MS-associated alleles is complex and implicated that difference in MS prevalence could be explained by the ancestry of MS-associated alleles.

Indexed as

Genetic Predisposition to DiseaseAllelesAsianBlack or African AmericanFemaleGenome-Wide Association StudyHaplotypesHispanic or LatinoHLA-A3 AntigenHLA-B7 AntigenHLA-DRB1 ChainsHumansMaleMultiple SclerosisPolymorphism, Single NucleotideTranscription FactorsHLA-A*03:01 antigenHLA-A3 AntigenHLA-B*07:02 antigenHLA-B7 AntigenHLA-DRB1*15:01 antigenHLA-DRB1 ChainsTranscription FactorsZNF597 protein, human

Identifiers

PMID30653506
PMCPMC6353231
OpenAlexW2908978047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.